A randomised trial showed a trend (but not significant) towards improved outcomes with a combination of anidulafungin and voriconazole compared to voriconazole alone for the treatment of IPA in patients with hematologic cancer [ 128 ].
← all excerpts
Management of Invasive Pulmonary Aspergillosis in Intensive Care Units: Guidelines From the Fungal Infection Network of Switzerland (FUNGINOS).
1
—
—